Life Sciences

35+ years representing leading global life sciences companies

    Practices

  • Corporate
  • Litigation
  • Regulatory
  • Intellectual Property
  • #1 in global biotech and pharma licensing transactions 2010 – 2015

  • #1 in issuer-side life sciences IPOs since 2000

  • #1 in life sciences venture financings 2013 – 2015

  • 180+ life sciences M&A transactions since 2010

  • 50+ major corporate partnering and licensing deals in 2015

  • Dedicated, international practice group of 40+ professionals across the US, UK and China exclusively focused on corporate partnering, licensing, M&A and other commercial transactions specific to life sciences companies

Read more

  • Defended more life sciences companies in shareholder litigation filed over the past five years than any other firm

  • Achieved groundbreaking victories on behalf of life sciences clients in the US Supreme Court and California Supreme Court

  • Complete wins in commercially significant drug ownership and licensing disputes 

  •  Decades of experience litigating Hatch-Waxman matters for branded pharmaceutical companies

  •  Defend False Claims Act actions arising from allegations of billing/coding misconduct, patient safety and research misconduct, manufacturing deficiencies, other Food, Drug and Cosmetic Act  violations, drug pricing misconduct, federal and state anti-kickback law violations, and other relevant fraud and abuse laws led by local, state and federal civil and criminal government enforcers

  • Experience in more than 100+ state, federal and international courts, arbitral forums and administrative bodies

  • Team includes 7 Fellows of the American College of Trial Lawyers and 20+ former Assistant US Attorneys and Department of Justice lawyers

  • Ranked #4 Most Innovative Law Firm by the Financial Times – recognized for Protecting Clients Business for litigating on behalf of our clients 

Read more

  • Deep US and global experience providing regulatory counseling and advice on FDA, fraud & abuse, corporate compliance, contractual relationships, Sunshine Laws, reimbursement, government program price reporting, healthcare data privacy, licensure and accreditation, health reform counseling, regulatory due diligences, MHRA and CE Marking 

  • Advise all players in the evolving ecosystem, including payors, providers, LS companies, health IT and investors

  • As connectors to the ecosystem, we counsel clients on how to launch innovative products and services

  • Represent healthcare clients in connection with federal and state government investigations, inquiries, settlements and voluntary disclosures, leveraging subject matter expertise and litigation and negotiation experience

  • Counsel related to privacy and data protection, government contracts and government analytics practices provided by multidisciplinary team bolstered by industry-leading lawyers

  • Frequent contributors on groundbreaking regulatory topics at leading industry events, editorial boards and relevant media and publications

  • Market leader in life sciences — #1 in IPOs, M&A transactions, venture financings and licensing

Read more

  • 70+ person life sciences patent team across the US and UK (90% hold PhDs)

  • The largest life sciences patent practice in the US

  • In the last 5 years, prepared and filed nearly 10,000 patent applications

  • 150+ investor-side and company-side patent due diligence reviews since 2015

  • One of the most active IP litigation practices in the US with 500+ cases in the last 5 years

  • Complete wins in commercially significant drug ownership and licensing disputes

  • Decades of experience litigating Hatch-Waxman matters for branded pharmaceutical companies 

  • Specialized branding team provides guidance on selecting, clearing, protecting and obtaining regulatory approval for drug and device names

  • Finalist for The American Lawyer’s 2015 IP Litigation Department of the Year award for bet-the-company wins including for Gilead and Gevo

Read more

Group Contacts
Barbara Kosacz Partner, Palo Alto
Laura Berezin Partner, Palo Alto
Barbara Borden Partner, San Diego
Tom Coll Partner, San Diego
Michael Tuscan Partner in Charge - Washington DC, Washington, DC
Ivor Elrifi Partner, New York
Sonya Erickson Partner, Seattle
Wainwright Fishburn Partner, San Diego
Robert L. Jones Partner, Palo Alto
Wendy Goldstein Partner, New York
Mika Reiner Mayer Partner, Palo Alto
Fred Muto Partner, San Diego
Marc Recht Partner, Boston
Christian Plaza Partner, Reston
Michelle Rhyu Partner, Palo Alto
John Wilkinson Partner, London
Christina Zhang Partner, Shanghai
ViewHide related contacts


Error

Listing Returned 0 Results.

ViewHide related news


Error

Listing Returned 0 Results.

ViewHide related events


Error

Listing Returned 0 Results.

According to industry peers, the licensing, tax and inversion, private investment, capital market and M&A work performed by Cooley is top tier. - LMG Life Sciences

TheBeat @ CooleyHealth

Updates and news related to health regulatory issues.

View blog